Riders · The University of Texas Southwestern Medical Center · Article III: Agencies of Education

Center for Regenerative Science and Medicine

Rider 5 in the 2026-27 Act, page III-219

Through the session

  1. 2024-25 Act In current law rider 5
  2. Introduced (Senate) Amended rider 4
  3. Introduced (House) Amended rider 4
  4. Senate substitute Unchanged rider 4
  5. House substitute Unchanged rider 4
  6. House passed Unchanged rider 4
  7. Conference Unchanged rider 5
  8. 2026-27 Act Unchanged rider 5

Pick any two steps to compare their wording.

What changed in the text

2024-25 Act → Introduced (House): 2 passages changed.

Center for Regenerative Science and Medicine. Out of funds appropriated above in Strategy B.1.2, Performance Based Research Operations, $7,296,000 in from the General Revenue Fund each fiscal year shall be used for the Center for Regenerative Science and Medicine.

Removed words are struck through; added words are underlined. Sources: 2024-25 Act · Introduced (House).

Every version: numbers, statuses and source pages
VersionRider Against the version beforeAgainst the current budget Source
2024-25 ActGeneral Appropriations Act, 2024-25 Biennium 5 First version — Page III-194
Introduced (Senate)Senate Bill 1 as introduced (LBB recommended, Senate) 4 was 5 Amended — Page III-193
Introduced (House)House Bill 1 as introduced (LBB recommended, House) 4 was 5 Amended — Page III-191
Senate substituteCommittee Substitute for Senate Bill 1 4 Unchanged Amended Page III-181
House substituteHouse Committee Substitute for Senate Bill 1 4 Unchanged Amended Page III-183
House passedSenate Bill 1 as passed the second house 4 Unchanged Amended Page III-184
ConferenceConference Committee Report for Senate Bill 1 5 was 4 Unchanged Amended Page III-195
2026-27 ActGeneral Appropriations Act, 2026-27 Biennium 5 Unchanged Amended Page III-219
Full text of each wording

Introduced (Senate), Introduced (House), Senate substitute, House substitute, House passed, Conference, 2026-27 Act

Source, page III-219

Center for Regenerative Science and Medicine. Out of funds appropriated above in Strategy B.1.2, Performance Based Research Operations, $7,296,000 from the General Revenue Fund each fiscal year shall be used for the Center for Regenerative Science and Medicine.

2024-25 Act

Source, page III-194

Center for Regenerative Science and Medicine. Out of funds appropriated above in Strategy B.1.2, Performance Based Research Operations, $7,296,000 in General Revenue each fiscal year shall be used for the Center for Regenerative Science and Medicine.